BGM Group (BGM) vs Retension Pharmaceuticals (RTSN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 18, 2026.
Summary
Retension Pharmaceuticals is the larger company by market cap ($117.2 million vs $115.5 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BGM | RTSN |
|---|---|---|
| Share price | $8.65 | $14.07 |
| Market cap | $115.51M | $117.23M |
| 1-day change | +0.70% | +15.23% |
| YTD return | -92.19% | — |
| 1-year return | -96.86% | — |
| 5-year return | -98.52% | — |
| EPS (TTM) | $-4.80 | $-2.61 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $37.92M | — |
| Revenue growth (YoY) | +51.09% | — |
| Net income (latest FY) | $-19.94M | — |
| Gross margin | 16.64% | — |
| Operating margin | -33.18% | — |
| Net margin | -52.59% | — |
| 52-week high | $303.00 | $14.97 |
| 52-week low | $6.45 | $9.66 |
| Distance from 52-week high | -97.15% | -6.02% |
| Average volume | 6.33K | 252.97K |
| Shares outstanding | 12.69M | 8.33M |
| Employees | — | 12 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About BGM Group
BGM stock →BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. The company operates through Diversified Pharmaceutical and Allied Products; AI Solution; and Insurance Business segments.
Health Care · Biotechnology: Pharmaceutical Preparations
About Retension Pharmaceuticals
RTSN stock →Retension Pharmaceuticals, Inc. operates as a clinical -stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 12 employees
BGM vs RTSN FAQ
Which is bigger, BGM Group or Retension Pharmaceuticals?
Retension Pharmaceuticals (RTSN) is larger, with a market capitalization of $117.23M compared with $115.51M for BGM Group (BGM).
Are BGM Group and Retension Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.